Mar04 Call for Papers: Real World Evidence The Real World Evidence (RWE) themed issue will focus on the evolving field and increasing importa... Read More.. Mar04 ASCPT News: March 2021 Stay up to date on the latest in clinical pharmacology and translational science. Read More.. Mar02 FDA News: Issue 5, March 2021 FDA Announces Availability of a Federal Register Notice to Solicit Public Comments to Inform a Publ... Read More.. Mar01 I am ASCPT: Mohamed H. Shahin Mohamed H. Shahin, PhD, Manager, Clinical Pharmacology Lead, Pfizer, Groton, CT Read More.. Mar01 I am ASCPT: Kathryn Momary Kathryn, Momary, PharmD, Assistant Professor, Mercer University, Atlanta, GA Read More.. Mar01 I am ASCPT: Akiyuki Suzuki Akiyuki Suzuki, PhD, Senior Manager, Pfizer, Tokyo, Japan Read More.. Mar01 I am ASCPT: Angela Kashuba Angela Kashuba, PharmD, Dean and Professor, University of North Carolina at Chapel Hill, Chapel Hill... Read More.. Feb23 FDA News: Issue 4, February 2021 FDA Office of Clinical Pharmacology Announces Availability of 2020 Annual Report Read More.. Feb15 FDA News: Issue 4, February 2021 FDA Approves CABENUVA (Cabotegravir and Rilpivirine) and VOCABRIA (Cabotegravir) for HIV in Patie... Read More.. Feb15 FDA News: Issue 3, February 2021 FDA Announces a Virtual Workshop Entitled “Roadmap to 2030 for New Drug Evaluation in Older Adult... Read More.. Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 of 37
Mar04 ASCPT News: March 2021 Stay up to date on the latest in clinical pharmacology and translational science. Read More.. Mar02 FDA News: Issue 5, March 2021 FDA Announces Availability of a Federal Register Notice to Solicit Public Comments to Inform a Publ... Read More.. Mar01 I am ASCPT: Mohamed H. Shahin Mohamed H. Shahin, PhD, Manager, Clinical Pharmacology Lead, Pfizer, Groton, CT Read More.. Mar01 I am ASCPT: Kathryn Momary Kathryn, Momary, PharmD, Assistant Professor, Mercer University, Atlanta, GA Read More.. Mar01 I am ASCPT: Akiyuki Suzuki Akiyuki Suzuki, PhD, Senior Manager, Pfizer, Tokyo, Japan Read More.. Mar01 I am ASCPT: Angela Kashuba Angela Kashuba, PharmD, Dean and Professor, University of North Carolina at Chapel Hill, Chapel Hill... Read More.. Feb23 FDA News: Issue 4, February 2021 FDA Office of Clinical Pharmacology Announces Availability of 2020 Annual Report Read More.. Feb15 FDA News: Issue 4, February 2021 FDA Approves CABENUVA (Cabotegravir and Rilpivirine) and VOCABRIA (Cabotegravir) for HIV in Patie... Read More.. Feb15 FDA News: Issue 3, February 2021 FDA Announces a Virtual Workshop Entitled “Roadmap to 2030 for New Drug Evaluation in Older Adult... Read More.. Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 of 37
Mar02 FDA News: Issue 5, March 2021 FDA Announces Availability of a Federal Register Notice to Solicit Public Comments to Inform a Publ... Read More.. Mar01 I am ASCPT: Mohamed H. Shahin Mohamed H. Shahin, PhD, Manager, Clinical Pharmacology Lead, Pfizer, Groton, CT Read More.. Mar01 I am ASCPT: Kathryn Momary Kathryn, Momary, PharmD, Assistant Professor, Mercer University, Atlanta, GA Read More.. Mar01 I am ASCPT: Akiyuki Suzuki Akiyuki Suzuki, PhD, Senior Manager, Pfizer, Tokyo, Japan Read More.. Mar01 I am ASCPT: Angela Kashuba Angela Kashuba, PharmD, Dean and Professor, University of North Carolina at Chapel Hill, Chapel Hill... Read More.. Feb23 FDA News: Issue 4, February 2021 FDA Office of Clinical Pharmacology Announces Availability of 2020 Annual Report Read More.. Feb15 FDA News: Issue 4, February 2021 FDA Approves CABENUVA (Cabotegravir and Rilpivirine) and VOCABRIA (Cabotegravir) for HIV in Patie... Read More.. Feb15 FDA News: Issue 3, February 2021 FDA Announces a Virtual Workshop Entitled “Roadmap to 2030 for New Drug Evaluation in Older Adult... Read More.. Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 of 37
Mar01 I am ASCPT: Mohamed H. Shahin Mohamed H. Shahin, PhD, Manager, Clinical Pharmacology Lead, Pfizer, Groton, CT Read More.. Mar01 I am ASCPT: Kathryn Momary Kathryn, Momary, PharmD, Assistant Professor, Mercer University, Atlanta, GA Read More.. Mar01 I am ASCPT: Akiyuki Suzuki Akiyuki Suzuki, PhD, Senior Manager, Pfizer, Tokyo, Japan Read More.. Mar01 I am ASCPT: Angela Kashuba Angela Kashuba, PharmD, Dean and Professor, University of North Carolina at Chapel Hill, Chapel Hill... Read More.. Feb23 FDA News: Issue 4, February 2021 FDA Office of Clinical Pharmacology Announces Availability of 2020 Annual Report Read More.. Feb15 FDA News: Issue 4, February 2021 FDA Approves CABENUVA (Cabotegravir and Rilpivirine) and VOCABRIA (Cabotegravir) for HIV in Patie... Read More.. Feb15 FDA News: Issue 3, February 2021 FDA Announces a Virtual Workshop Entitled “Roadmap to 2030 for New Drug Evaluation in Older Adult... Read More.. Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 of 37
Mar01 I am ASCPT: Kathryn Momary Kathryn, Momary, PharmD, Assistant Professor, Mercer University, Atlanta, GA Read More.. Mar01 I am ASCPT: Akiyuki Suzuki Akiyuki Suzuki, PhD, Senior Manager, Pfizer, Tokyo, Japan Read More.. Mar01 I am ASCPT: Angela Kashuba Angela Kashuba, PharmD, Dean and Professor, University of North Carolina at Chapel Hill, Chapel Hill... Read More.. Feb23 FDA News: Issue 4, February 2021 FDA Office of Clinical Pharmacology Announces Availability of 2020 Annual Report Read More.. Feb15 FDA News: Issue 4, February 2021 FDA Approves CABENUVA (Cabotegravir and Rilpivirine) and VOCABRIA (Cabotegravir) for HIV in Patie... Read More.. Feb15 FDA News: Issue 3, February 2021 FDA Announces a Virtual Workshop Entitled “Roadmap to 2030 for New Drug Evaluation in Older Adult... Read More.. Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 of 37
Mar01 I am ASCPT: Akiyuki Suzuki Akiyuki Suzuki, PhD, Senior Manager, Pfizer, Tokyo, Japan Read More.. Mar01 I am ASCPT: Angela Kashuba Angela Kashuba, PharmD, Dean and Professor, University of North Carolina at Chapel Hill, Chapel Hill... Read More.. Feb23 FDA News: Issue 4, February 2021 FDA Office of Clinical Pharmacology Announces Availability of 2020 Annual Report Read More.. Feb15 FDA News: Issue 4, February 2021 FDA Approves CABENUVA (Cabotegravir and Rilpivirine) and VOCABRIA (Cabotegravir) for HIV in Patie... Read More.. Feb15 FDA News: Issue 3, February 2021 FDA Announces a Virtual Workshop Entitled “Roadmap to 2030 for New Drug Evaluation in Older Adult... Read More.. Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 of 37
Mar01 I am ASCPT: Angela Kashuba Angela Kashuba, PharmD, Dean and Professor, University of North Carolina at Chapel Hill, Chapel Hill... Read More.. Feb23 FDA News: Issue 4, February 2021 FDA Office of Clinical Pharmacology Announces Availability of 2020 Annual Report Read More.. Feb15 FDA News: Issue 4, February 2021 FDA Approves CABENUVA (Cabotegravir and Rilpivirine) and VOCABRIA (Cabotegravir) for HIV in Patie... Read More.. Feb15 FDA News: Issue 3, February 2021 FDA Announces a Virtual Workshop Entitled “Roadmap to 2030 for New Drug Evaluation in Older Adult... Read More.. Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 of 37
Feb23 FDA News: Issue 4, February 2021 FDA Office of Clinical Pharmacology Announces Availability of 2020 Annual Report Read More.. Feb15 FDA News: Issue 4, February 2021 FDA Approves CABENUVA (Cabotegravir and Rilpivirine) and VOCABRIA (Cabotegravir) for HIV in Patie... Read More.. Feb15 FDA News: Issue 3, February 2021 FDA Announces a Virtual Workshop Entitled “Roadmap to 2030 for New Drug Evaluation in Older Adult... Read More.. Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 of 37
Feb15 FDA News: Issue 4, February 2021 FDA Approves CABENUVA (Cabotegravir and Rilpivirine) and VOCABRIA (Cabotegravir) for HIV in Patie... Read More.. Feb15 FDA News: Issue 3, February 2021 FDA Announces a Virtual Workshop Entitled “Roadmap to 2030 for New Drug Evaluation in Older Adult... Read More.. Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 of 37
Feb15 FDA News: Issue 3, February 2021 FDA Announces a Virtual Workshop Entitled “Roadmap to 2030 for New Drug Evaluation in Older Adult... Read More.. Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 of 37